Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Pharmaceutical biotechnology : fundamentals and essentials / Melvin E. Klegerman, Michael J. Groves
| Pharmaceutical biotechnology : fundamentals and essentials / Melvin E. Klegerman, Michael J. Groves |
| Autore | Klegerman, Melvin E. |
| Pubbl/distr/stampa | Buffalo Grove, Il : Interpharm Press, c1992 |
| Descrizione fisica | xvii, 295 p. : ill. ; 26 cm |
| Disciplina | 615.19 |
| Altri autori (Persone) | Groves, Michael J. |
| Soggetto topico |
Biotechnology - Methods
Pharmaceutical biotechnology Pharmaceutical industry Technology, Pharmaceutical - Methods |
| ISBN | 0935184376 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991003537979707536 |
Klegerman, Melvin E.
|
||
| Buffalo Grove, Il : Interpharm Press, c1992 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
Pharmaceutical biotechnology [[electronic resource] /] / K. Sambamurthy, Ashutosh Kar
| Pharmaceutical biotechnology [[electronic resource] /] / K. Sambamurthy, Ashutosh Kar |
| Autore | Sambamurthy K |
| Pubbl/distr/stampa | New Delhi, : New Age International (P) Ltd., Publishers, c2006 |
| Descrizione fisica | 1 online resource (502 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) | KarAshutosh |
| Soggetto topico |
Pharmaceutical biotechnology
Biotechnology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-99288-7
9786611992880 81-224-2424-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Foreword; Preface; Contents; Chapter 1 Immunology and Immunological Preparations; Chapter 2 Genetic Recombination; Chapter 3 Antibiotics; Chapter 4 Microbial Transformations; Chapter 5 Enzyme Immobilization; Chapter 6 Advent of Biotechnology; Chapter 7 Biosensor Technology; Chapter 8 Bioinformatics and Data Mining; Chapter 9 Regulatory Issues in Biotechnology; Chapter 10 Safety in Biotechnology; Glossary; Index |
| Record Nr. | UNINA-9910453979903321 |
|
Sambamurthy K
|
||
| New Delhi, : New Age International (P) Ltd., Publishers, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical biotechnology / / K. Sambamurthy, Ashutosh Kar
| Pharmaceutical biotechnology / / K. Sambamurthy, Ashutosh Kar |
| Autore | Sambamurthy K |
| Pubbl/distr/stampa | New Delhi : , : New Age International (P) Ltd., Publishers, , 2006 |
| Descrizione fisica | 1 online resource (xx, 481 pages) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) | KarAshutosh |
| Soggetto topico |
Pharmaceutical biotechnology
Biotechnology |
| ISBN |
1-281-99288-7
9786611992880 81-224-2424-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Foreword; Preface; Contents; Chapter 1 Immunology and Immunological Preparations; Chapter 2 Genetic Recombination; Chapter 3 Antibiotics; Chapter 4 Microbial Transformations; Chapter 5 Enzyme Immobilization; Chapter 6 Advent of Biotechnology; Chapter 7 Biosensor Technology; Chapter 8 Bioinformatics and Data Mining; Chapter 9 Regulatory Issues in Biotechnology; Chapter 10 Safety in Biotechnology; Glossary; Index |
| Record Nr. | UNINA-9910782688403321 |
|
Sambamurthy K
|
||
| New Delhi : , : New Age International (P) Ltd., Publishers, , 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical biotechnology / / K. Sambamurthy, Ashutosh Kar
| Pharmaceutical biotechnology / / K. Sambamurthy, Ashutosh Kar |
| Autore | Sambamurthy K |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New Delhi : , : New Age International (P) Ltd., Publishers, , 2006 |
| Descrizione fisica | 1 online resource (xx, 481 pages) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) | KarAshutosh |
| Soggetto topico |
Pharmaceutical biotechnology
Biotechnology |
| ISBN |
1-281-99288-7
9786611992880 81-224-2424-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Foreword; Preface; Contents; Chapter 1 Immunology and Immunological Preparations; Chapter 2 Genetic Recombination; Chapter 3 Antibiotics; Chapter 4 Microbial Transformations; Chapter 5 Enzyme Immobilization; Chapter 6 Advent of Biotechnology; Chapter 7 Biosensor Technology; Chapter 8 Bioinformatics and Data Mining; Chapter 9 Regulatory Issues in Biotechnology; Chapter 10 Safety in Biotechnology; Glossary; Index |
| Record Nr. | UNINA-9910822047703321 |
|
Sambamurthy K
|
||
| New Delhi : , : New Age International (P) Ltd., Publishers, , 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical biotechnology [[electronic resource] ] : drug discovery and clinical applications / / edited by Oliver Kayser and Heribert Warzecha
| Pharmaceutical biotechnology [[electronic resource] ] : drug discovery and clinical applications / / edited by Oliver Kayser and Heribert Warzecha |
| Edizione | [2nd., completely rev. and greatly enl. ed.] |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, 2012 |
| Descrizione fisica | 1 online resource (677 p.) |
| Disciplina |
615.19
615/.19 |
| Altri autori (Persone) |
KayserOliver
WarzechaHeribert |
| Soggetto topico | Pharmaceutical biotechnology |
| ISBN |
1-280-66337-5
9786613640307 3-527-65126-8 3-527-63290-5 3-527-65125-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | pt. 1. Concepts and methods for recombinant drug production -- pt. 2. Bringing the drug into action : from downstreaming to approval -- pt. 3. Vaccines -- pt. 4. Recent applications in pharmaceutical biotechnology. |
| Record Nr. | UNINA-9910141290003321 |
| Weinheim, : Wiley-Blackwell, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacognosy and pharmacobiotechnology [[electronic resource] /] / Ashutosh Kar
| Pharmacognosy and pharmacobiotechnology [[electronic resource] /] / Ashutosh Kar |
| Autore | Kar Ashutosh |
| Edizione | [rev.-expanded 2nd ed.] |
| Pubbl/distr/stampa | New Delhi, : New Age International (P) Ltd., c2007 |
| Descrizione fisica | 1 online resource (898 p.) |
| Soggetto topico |
Pharmaceutical biotechnology
Pharmacognosy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
81-224-2915-7
9786612385704 1-282-38570-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover ""; ""Preface to the Second Edition ""; ""Preface to the First Edition ""; ""Contents ""; ""Chapter 1. Introduction ""; ""1.1 Pharmacognosy-A Brief History ""; ""1.2 Importance of Natural Drug Substances ""; ""1.2.1 Serve as Extremely Useful Natural Drugs""; ""1.2.2 Provide Basic Compounds Affording Less Toxic and More Effective Drug Molecules""; ""1.2.3 Exploration of Biological�Active�Prototypes towards Newer and Better Synthetic Drugs""; ""1.2.4 Modificaton of Inactive Natural Products by Suitable Biological/Chemical Means into Potent Drugs""
""1.3 Natural Drugs Substances: Cultivation and Production """"1.3.1 Plant Products""; ""1.3.2 Cell-Culture Techniques""; ""1.3.3 Microbial Metabolites""; ""1.3.4 Animal Derivatives""; ""1.4 Phytochemistry ""; ""1.4.1 Constituents""; ""Chapter 2. Pharmacobiotechnology ""; ""2.1 Introduction ""; ""2.2 Theory ""; ""2.2.1 Mutation, Crossing-over and Recombinant of Meiosis""; ""2.2.2 Third Revolution in Modern Medicine""; ""2.2.3 Genetic Code""; ""2.2.4 Specific Sets of Genes in Each Individual Organ""; ""2.2.5 Reverse Transcriptase (RT)""; ""2.2.6 3D-Proteins"" ""2.2.7 From Nervous System to Immune System""""2.2.8 Body�s Defence Mechanism""; ""2.2.9 PCR�in Forensic & Research""; ""2.2.10 DNA�in Metabolic Pathways""; ""2.2.11 Recombinant Vaccination Vector""; ""2.2.12 OKT3�Monoclonal Antibody""; ""2.3 Important Means in Biotechnology ""; ""2.3.1 Recombinant DNA (rDNA)""; ""2.3.2 Restriction Enzymes""; ""2.3.3 DNA�Ligase""; ""2.3.4 Cloning Vector""; ""2.3.5 Hybridization Probes""; ""2.3.6 Cloning Process""; ""2.4 Recombinant Proteins ""; ""2.4.1 Bacterial Systems""; ""2.4.2 Glycosylation"" ""2.4.3 Mammalian Tissue Culture Expression Systems""""2.5 Biotechnology Vs Modern Pharmacy Practice ""; ""2.5.1 Human Proteins as Drugs""; ""2.5.2 New Drug Classes""; ""2.5.3 Vaccines""; ""2.5.4 New Immunodiagnostic Agents""; ""2.5.5 DNA Probes and RFLP Analysis""; ""2.5.6 Enzyme Linked Immunosorbant Assay (ELISA)""; ""2.6 Biotechnology Based Pharmaceuticlas for the Millennium ""; ""2.6.1 Genetically Engineered Vaccine""; ""2.6.2 Gene Splicing and DNA Recombinant Procedures""; ""2.6.3 Antibodies in Biotechnology""; ""2.6.4 Gene Therapy""; ""2.6.5 3D Picture of the �Lock� and �Keys�"" ""2.7 Biotechnology and Modern Drug Discovery """"2.7.1 Approved Medicines""; ""2.7.2 Medicines Under Development""; ""2.7.3 Human Clone""; ""2.8 Biotechnolgy: Some Thought Provoking Newer Ideas ""; ""2.8.1 Potato Vaccine""; ""2.8.2 Functional Food Revolution""; ""Chapter 3. Carbobhydrates ""; ""3.1 Introductioin ""; ""3.2 Classification ""; ""3.2.1 Homoglycans""; ""3.2.2 Heteroglycans""; ""3.3 Carbohydrate Biogenesis ""; ""Chapter 4. Glycosides ""; ""4.1 Introduction ""; ""4.1.1 O-Glycosides""; ""4.1.2 S-Glycosides""; ""4.1.3 N-Glycosides""; ""4.1.4 C-Glycosides""; ""4.2 Classification "" ""4.2.1 Anthracene Glycosides (or Anthraquinone Glycosides)"" |
| Record Nr. | UNINA-9910458771603321 |
|
Kar Ashutosh
|
||
| New Delhi, : New Age International (P) Ltd., c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacognosy and pharmacobiotechnology / / Ashutosh Kar
| Pharmacognosy and pharmacobiotechnology / / Ashutosh Kar |
| Autore | Kar Ashutosh |
| Edizione | [rev.-expanded 2nd ed.] |
| Pubbl/distr/stampa | New Delhi, : New Age International (P) Ltd., c2007 |
| Descrizione fisica | 1 online resource (xvii, 879 pages) : illustrations |
| Soggetto topico |
Pharmaceutical biotechnology
Pharmacognosy |
| ISBN |
81-224-2915-7
9786612385704 1-282-38570-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover ""; ""Preface to the Second Edition ""; ""Preface to the First Edition ""; ""Contents ""; ""Chapter 1. Introduction ""; ""1.1 Pharmacognosy-A Brief History ""; ""1.2 Importance of Natural Drug Substances ""; ""1.2.1 Serve as Extremely Useful Natural Drugs""; ""1.2.2 Provide Basic Compounds Affording Less Toxic and More Effective Drug Molecules""; ""1.2.3 Exploration of Biological-Active-Prototypes towards Newer and Better Synthetic Drugs""; ""1.2.4 Modificaton of Inactive Natural Products by Suitable Biological/Chemical Means into Potent Drugs""
""1.3 Natural Drugs Substances: Cultivation and Production "" ""1.3.1 Plant Products""; ""1.3.2 Cell-Culture Techniques""; ""1.3.3 Microbial Metabolites""; ""1.3.4 Animal Derivatives""; ""1.4 Phytochemistry ""; ""1.4.1 Constituents""; ""Chapter 2. Pharmacobiotechnology ""; ""2.1 Introduction ""; ""2.2 Theory ""; ""2.2.1 Mutation, Crossing-over and Recombinant of Meiosis""; ""2.2.2 Third Revolution in Modern Medicine""; ""2.2.3 Genetic Code""; ""2.2.4 Specific Sets of Genes in Each Individual Organ""; ""2.2.5 Reverse Transcriptase (RT)""; ""2.2.6 3D-Proteins"" ""2.2.7 From Nervous System to Immune System""" "2.2.8 Body's Defence Mechanism""; ""2.2.9 PCR: in Forensic & Research""; ""2.2.10 DNA: in Metabolic Pathways""; ""2.2.11 Recombinant Vaccination Vector""; ""2.2.12 OKT3: Monoclonal Antibody""; ""2.3 Important Means in Biotechnology ""; ""2.3.1 Recombinant DNA (rDNA)""; ""2.3.2 Restriction Enzymes""; ""2.3.3 DNA: Ligase""; ""2.3.4 Cloning Vector""; ""2.3.5 Hybridization Probes""; ""2.3.6 Cloning Process""; ""2.4 Recombinant Proteins ""; ""2.4.1 Bacterial Systems""; ""2.4.2 Glycosylation"" ""2.4.3 Mammalian Tissue Culture Expression Systems""" "2.5 Biotechnology Vs Modern Pharmacy Practice ""; ""2.5.1 Human Proteins as Drugs""; ""2.5.2 New Drug Classes""; ""2.5.3 Vaccines""; ""2.5.4 New Immunodiagnostic Agents""; ""2.5.5 DNA Probes and RFLP Analysis""; ""2.5.6 Enzyme Linked Immunosorbant Assay (ELISA)""; ""2.6 Biotechnology Based Pharmaceuticals for the Millennium ""; ""2.6.1 Genetically Engineered Vaccine""; ""2.6.2 Gene Splicing and DNA Recombinant Procedures""; ""2.6.3 Antibodies in Biotechnology""; ""2.6.4 Gene Therapy""; ""2.6.5 3D Picture of the Lock and Keys"" ""2.7 Biotechnology and Modern Drug Discovery "" ""2.7.1 Approved Medicines""; ""2.7.2 Medicines Under Development""; ""2.7.3 Human Clone""; ""2.8 Biotechnology: Some Thought Provoking Newer Ideas ""; ""2.8.1 Potato Vaccine""; ""2.8.2 Functional Food Revolution""; ""Chapter 3. Carbohydrates ""; ""3.1 Introduction ""; ""3.2 Classification ""; ""3.2.1 Homoglycans""; ""3.2.2 Heteroglycans""; ""3.3 Carbohydrate Biogenesis ""; ""Chapter 4. Glycosides ""; ""4.1 Introduction ""; ""4.1.1 O-Glycosides""; ""4.1.2 S-Glycosides""; ""4.1.3 N-Glycosides""; ""4.1.4 C-Glycosides""; ""4.2 Classification ""; ""4.2.1 Anthracene Glycosides (or Anthraquinone Glycosides)"" |
| Record Nr. | UNINA-9910792447803321 |
|
Kar Ashutosh
|
||
| New Delhi, : New Age International (P) Ltd., c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacognosy and pharmacobiotechnology / / Ashutosh Kar
| Pharmacognosy and pharmacobiotechnology / / Ashutosh Kar |
| Autore | Kar Ashutosh |
| Edizione | [rev.-expanded 2nd ed.] |
| Pubbl/distr/stampa | New Delhi, : New Age International (P) Ltd., c2007 |
| Descrizione fisica | 1 online resource (xvii, 879 pages) : illustrations |
| Soggetto topico |
Pharmaceutical biotechnology
Pharmacognosy |
| ISBN |
81-224-2915-7
9786612385704 1-282-38570-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover ""; ""Preface to the Second Edition ""; ""Preface to the First Edition ""; ""Contents ""; ""Chapter 1. Introduction ""; ""1.1 Pharmacognosy-A Brief History ""; ""1.2 Importance of Natural Drug Substances ""; ""1.2.1 Serve as Extremely Useful Natural Drugs""; ""1.2.2 Provide Basic Compounds Affording Less Toxic and More Effective Drug Molecules""; ""1.2.3 Exploration of Biological-Active-Prototypes towards Newer and Better Synthetic Drugs""; ""1.2.4 Modificaton of Inactive Natural Products by Suitable Biological/Chemical Means into Potent Drugs""
""1.3 Natural Drugs Substances: Cultivation and Production "" ""1.3.1 Plant Products""; ""1.3.2 Cell-Culture Techniques""; ""1.3.3 Microbial Metabolites""; ""1.3.4 Animal Derivatives""; ""1.4 Phytochemistry ""; ""1.4.1 Constituents""; ""Chapter 2. Pharmacobiotechnology ""; ""2.1 Introduction ""; ""2.2 Theory ""; ""2.2.1 Mutation, Crossing-over and Recombinant of Meiosis""; ""2.2.2 Third Revolution in Modern Medicine""; ""2.2.3 Genetic Code""; ""2.2.4 Specific Sets of Genes in Each Individual Organ""; ""2.2.5 Reverse Transcriptase (RT)""; ""2.2.6 3D-Proteins"" ""2.2.7 From Nervous System to Immune System""" "2.2.8 Body's Defence Mechanism""; ""2.2.9 PCR: in Forensic & Research""; ""2.2.10 DNA: in Metabolic Pathways""; ""2.2.11 Recombinant Vaccination Vector""; ""2.2.12 OKT3: Monoclonal Antibody""; ""2.3 Important Means in Biotechnology ""; ""2.3.1 Recombinant DNA (rDNA)""; ""2.3.2 Restriction Enzymes""; ""2.3.3 DNA: Ligase""; ""2.3.4 Cloning Vector""; ""2.3.5 Hybridization Probes""; ""2.3.6 Cloning Process""; ""2.4 Recombinant Proteins ""; ""2.4.1 Bacterial Systems""; ""2.4.2 Glycosylation"" ""2.4.3 Mammalian Tissue Culture Expression Systems""" "2.5 Biotechnology Vs Modern Pharmacy Practice ""; ""2.5.1 Human Proteins as Drugs""; ""2.5.2 New Drug Classes""; ""2.5.3 Vaccines""; ""2.5.4 New Immunodiagnostic Agents""; ""2.5.5 DNA Probes and RFLP Analysis""; ""2.5.6 Enzyme Linked Immunosorbant Assay (ELISA)""; ""2.6 Biotechnology Based Pharmaceuticals for the Millennium ""; ""2.6.1 Genetically Engineered Vaccine""; ""2.6.2 Gene Splicing and DNA Recombinant Procedures""; ""2.6.3 Antibodies in Biotechnology""; ""2.6.4 Gene Therapy""; ""2.6.5 3D Picture of the Lock and Keys"" ""2.7 Biotechnology and Modern Drug Discovery "" ""2.7.1 Approved Medicines""; ""2.7.2 Medicines Under Development""; ""2.7.3 Human Clone""; ""2.8 Biotechnology: Some Thought Provoking Newer Ideas ""; ""2.8.1 Potato Vaccine""; ""2.8.2 Functional Food Revolution""; ""Chapter 3. Carbohydrates ""; ""3.1 Introduction ""; ""3.2 Classification ""; ""3.2.1 Homoglycans""; ""3.2.2 Heteroglycans""; ""3.3 Carbohydrate Biogenesis ""; ""Chapter 4. Glycosides ""; ""4.1 Introduction ""; ""4.1.1 O-Glycosides""; ""4.1.2 S-Glycosides""; ""4.1.3 N-Glycosides""; ""4.1.4 C-Glycosides""; ""4.2 Classification ""; ""4.2.1 Anthracene Glycosides (or Anthraquinone Glycosides)"" |
| Record Nr. | UNINA-9910824741603321 |
|
Kar Ashutosh
|
||
| New Delhi, : New Age International (P) Ltd., c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacokinetics and pharmacodynamics of biotech drugs : principles and case studies in drug development / / edited by Bernd Meibohm
| Pharmacokinetics and pharmacodynamics of biotech drugs : principles and case studies in drug development / / edited by Bernd Meibohm |
| Pubbl/distr/stampa | Weinheim, Germany, : Wiley-VCH, c2006 |
| Descrizione fisica | 1 online resource (427 pages) |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical biotechnology
Pharmacokinetics Drugs - Physiological effect Drug development |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-72291-6
9786610722914 3-527-60962-8 3-527-60952-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs -- 2. Pharmacokinetics of Peptides and Proteins -- 3. Pharmacokinetics of Monoclonal Antibodies -- 4. Pharmacokinetics and Pharmacodynamics of Antisense Oligonucleotides -- 5. Pharmacokinetics of Viral and Non-Viral Gene Delivery Vectors -- 6. Bioanalytical Methods Used for Pharmacokinetic Evaluationsof Biotech Macromolecule Drugs: Issues, Assay Approaches, and Limitations -- 7. Limitations of Noncompartmental Pharmacokinetic Analysisof Biotech Drugs -- 8. Bioequivalence of Biologics -- 9. Biopharmaceutical Challenges: Pulmonary Delivery of Proteinsand Peptides -- 10. Biopharmaceutical Challenges: Delivery of Oligonucleotides -- 11. Custom-Tailored Pharmacokinetics and Pharmacodynamicsvia Chemical Modifications of Biotech Drugs -- 12. Exposure–Response Relationships for Therapeutic BiologicProducts -- 13. Preclinical and Clinical Drug Development of Tasidotin,a Depsi-Pentapeptide Oncolytic Agent. |
| Record Nr. | UNINA-9910144562503321 |
| Weinheim, Germany, : Wiley-VCH, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacokinetics and pharmacodynamics of biotech drugs : principles and case studies in drug development / / edited by Bernd Meibohm
| Pharmacokinetics and pharmacodynamics of biotech drugs : principles and case studies in drug development / / edited by Bernd Meibohm |
| Pubbl/distr/stampa | Weinheim, Germany, : Wiley-VCH, c2006 |
| Descrizione fisica | 1 online resource (427 pages) |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical biotechnology
Pharmacokinetics Drugs - Physiological effect Drug development |
| ISBN |
1-280-72291-6
9786610722914 3-527-60962-8 3-527-60952-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs -- 2. Pharmacokinetics of Peptides and Proteins -- 3. Pharmacokinetics of Monoclonal Antibodies -- 4. Pharmacokinetics and Pharmacodynamics of Antisense Oligonucleotides -- 5. Pharmacokinetics of Viral and Non-Viral Gene Delivery Vectors -- 6. Bioanalytical Methods Used for Pharmacokinetic Evaluationsof Biotech Macromolecule Drugs: Issues, Assay Approaches, and Limitations -- 7. Limitations of Noncompartmental Pharmacokinetic Analysisof Biotech Drugs -- 8. Bioequivalence of Biologics -- 9. Biopharmaceutical Challenges: Pulmonary Delivery of Proteinsand Peptides -- 10. Biopharmaceutical Challenges: Delivery of Oligonucleotides -- 11. Custom-Tailored Pharmacokinetics and Pharmacodynamicsvia Chemical Modifications of Biotech Drugs -- 12. Exposure–Response Relationships for Therapeutic BiologicProducts -- 13. Preclinical and Clinical Drug Development of Tasidotin,a Depsi-Pentapeptide Oncolytic Agent. |
| Record Nr. | UNINA-9910677047403321 |
| Weinheim, Germany, : Wiley-VCH, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
